{"title":"Tribulus platypterus-Reduced Ag Nanoparticles Ameliorate the Hemogram and Iron Indices in Renal Anemia Rat Model","authors":"Rui Zhang, Enzhe Zhao, Jieyu Chen, Rongshan Li","doi":"10.1002/aoc.7987","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The recent study evaluated the protective effect of the <i>Tribulus platypterus</i> green-synthesized silver nanoparticles against gentamicin-induced nephrotoxicity. The silver nanoparticles were characterized using XRD, UV-Vis, FT-IR, and FE-SEM. The nanoparticles exhibited a spherical morphology with an average diameter of 48 nm. Both traditional and innovative kidney injury indicators were employed to evaluate the nephroprotective effects of nanoparticles in a rat model. Administration of gentamicin resulted in a significant reduction (<i>p</i> ≤ 0.01) in Hb concentration, PCV, and RBC count. Conversely, the levels of creatinine, erythropoietin, serum iron, and urea increased significantly (<i>p</i> ≤ 0.01) in the gentamicin-treated group. The leucogram indicated the presence of leukocytosis, granulocytosis, and thrombocytopenia. Silver nanoparticles enhanced the parameters related to iron, leukogram, thrombocytes, erythropoietin, and erythrogram. In animals administered AgNPs, there was a significant decrease in the concentrations of creatinine, urea, AST, ALT, GGT, and ALP, whereas total protein and albumin levels showed a significant increase. Furthermore, AgNPs notably increased the levels of IL5, IL10, TGFβ, IL3, and IL4, while simultaneously reducing the levels of TNFα, IL6, IL12, IL18, and IL1. These results suggest that AgNPs could serve as a valuable nephroprotective agent derived from a biological source, potentially making them a suitable therapeutic supplement for conditions related to blood disorders.</p>\n </div>","PeriodicalId":8344,"journal":{"name":"Applied Organometallic Chemistry","volume":"39 4","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Organometallic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/aoc.7987","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
The recent study evaluated the protective effect of the Tribulus platypterus green-synthesized silver nanoparticles against gentamicin-induced nephrotoxicity. The silver nanoparticles were characterized using XRD, UV-Vis, FT-IR, and FE-SEM. The nanoparticles exhibited a spherical morphology with an average diameter of 48 nm. Both traditional and innovative kidney injury indicators were employed to evaluate the nephroprotective effects of nanoparticles in a rat model. Administration of gentamicin resulted in a significant reduction (p ≤ 0.01) in Hb concentration, PCV, and RBC count. Conversely, the levels of creatinine, erythropoietin, serum iron, and urea increased significantly (p ≤ 0.01) in the gentamicin-treated group. The leucogram indicated the presence of leukocytosis, granulocytosis, and thrombocytopenia. Silver nanoparticles enhanced the parameters related to iron, leukogram, thrombocytes, erythropoietin, and erythrogram. In animals administered AgNPs, there was a significant decrease in the concentrations of creatinine, urea, AST, ALT, GGT, and ALP, whereas total protein and albumin levels showed a significant increase. Furthermore, AgNPs notably increased the levels of IL5, IL10, TGFβ, IL3, and IL4, while simultaneously reducing the levels of TNFα, IL6, IL12, IL18, and IL1. These results suggest that AgNPs could serve as a valuable nephroprotective agent derived from a biological source, potentially making them a suitable therapeutic supplement for conditions related to blood disorders.
期刊介绍:
All new compounds should be satisfactorily identified and proof of their structure given according to generally accepted standards. Structural reports, such as papers exclusively dealing with synthesis and characterization, analytical techniques, or X-ray diffraction studies of metal-organic or organometallic compounds will not be considered. The editors reserve the right to refuse without peer review any manuscript that does not comply with the aims and scope of the journal. Applied Organometallic Chemistry publishes Full Papers, Reviews, Mini Reviews and Communications of scientific research in all areas of organometallic and metal-organic chemistry involving main group metals, transition metals, lanthanides and actinides. All contributions should contain an explicit application of novel compounds, for instance in materials science, nano science, catalysis, chemical vapour deposition, metal-mediated organic synthesis, polymers, bio-organometallics, metallo-therapy, metallo-diagnostics and medicine. Reviews of books covering aspects of the fields of focus are also published.